China Troxerutin Prices Drop 3% in January 2026 Amid Weak Pre-Holiday Demand

Troxerutin markets in China softened through January as a pre-Lunar-New-Year slowdown met rising domestic inventories and muted export demand. Early in the month, Troxerutin producers maintained normal operations, but mid-month buying failed to pick up meaningfully, and late-January activity cooled as distributors and formulators worked through safety stocks rather than expanding purchases. The combination of ample available volumes of Troxerutin and cautious procurement by both domestic and overseas buyers created a supply-heavy backdrop that pressured Troxerutin sellers to discount offers to keep shipment momentum ahead of the holiday period.

Demand across core end-use sectors remained subdued, reflecting the hesitant buying patterns of Troxerutin. Domestic pharmaceuticals, particularly vascular-health generics and eye-health nutraceutical makers, purchased only hand-to-mouth volumes, while cosmetics and personal-care firms showed interest in Troxerutin-containing actives for beauty formulations but did not convert short listings into bulk orders. In contrast, export distributors to India,...